888 filings
Page 9 of 45
4
ABUS
Arbutus Biopharma Corp
10 Feb 21
Arbutus Biopharma / Michael J. McElhaugh ownership change
5:06pm
SC 13G/A
ABUS
Arbutus Biopharma Corp
10 Feb 21
Arbutus Biopharma / MORGAN STANLEY ownership change
12:13pm
8-K
ABUS
Arbutus Biopharma Corp
1 Feb 21
Other Events
7:30am
8-K
ABUS
Arbutus Biopharma Corp
25 Jan 21
Arbutus Announces 2021 Corporate Objectives and Provides Financial Update
7:32am
4
McElhaugh Michael J.
16 Dec 20
Arbutus Biopharma / Michael J. McElhaugh ownership change
4:33pm
8-K
ABUS
Arbutus Biopharma Corp
10 Dec 20
Arbutus Announces Robust HBsAg Decline Data with AB-729 Dosed at 60 mg Every 8 Weeks in Chronic Hepatitis B Subjects
7:32am
8-K
ABUS
Arbutus Biopharma Corp
16 Nov 20
Other Events
8:00am
10-Q
2020 Q3
ABUS
Arbutus Biopharma Corp
Quarterly report
5 Nov 20
4:11pm
8-K
ABUS
Arbutus Biopharma Corp
5 Nov 20
Arbutus Reports Third Quarter 2020 Financial Results and Provides Corporate Update
8:30am
EFFECT
ABUS
Arbutus Biopharma Corp
23 Oct 20
Notice of effectiveness
12:15am
CORRESP
ABUS
Arbutus Biopharma Corp
21 Oct 20
Correspondence with SEC
12:00am
4
ABUS
Arbutus Biopharma Corp
25 Sep 20
Arbutus Biopharma / Gaston Picchio ownership change
4:06pm
4
Collier William H.
25 Sep 20
Arbutus Biopharma / William H. Collier ownership change
4:05pm
8-K
ABUS
Arbutus Biopharma Corp
15 Sep 20
Arbutus Announces AB-729 90 mg Single-Dose Week 12 Data in Chronic Hepatitis B Subjects Demonstrating Significant and Continuous Reductions in HBsAg
7:32am
UPLOAD
ABUS
Arbutus Biopharma Corp
3 Sep 20
Letter from SEC
12:00am
CT ORDER
ABUS
Arbutus Biopharma Corp
1 Sep 20
Confidential treatment order
4:39pm
S-3
ABUS
Arbutus Biopharma Corp
Shelf registration
28 Aug 20
4:06pm
8-K
ABUS
Arbutus Biopharma Corp
27 Aug 20
Other Events
8:17am
8-K
ABUS
Arbutus Biopharma Corp
10 Aug 20
Other Events
6:44am
8-K
ABUS
Arbutus Biopharma Corp
7 Aug 20
Entry into a Material Definitive Agreement
5:24pm